NCT03627845View on ClinicalTrials.gov

A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects

PHASE1CompletedINTERVENTIONAL
Enrollment

49

Participants

Timeline

Start Date

August 2, 2018

Primary Completion Date

December 5, 2018

Study Completion Date

January 8, 2020

Conditions
Healthy Volunteer
Interventions
DRUG

PHP-303

Investigational drug

OTHER

Placebo

Matching placebo

Trial Locations (1)

66212

Vince & Associates Clinical Research, Inc., Overland Park

Sponsors

Lead Sponsor

pH Pharma
All Listed Sponsors
lead

pH Pharma

INDUSTRY

NCT03627845 - A Study of Safety, Tolerability, and Pharmacokinetics of Single Doses of PHP-303 in Healthy Subjects | Biotech Hunter | Biotech Hunter